> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Annual Report on Post Marketing Requirements/Commitments
- URL: https://www.fdaweb.com/annual-report-on-post-marketing-requirements-commitments/
- Published: 2018-11-16T12:00:00.000Z
- Updated: 2026-09-15T00:45:16.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5142839

*Federal Register* notice: FDA has announced the availability of its annual report entitled “Report on the Performance of Drug and Biologics Firms in Conducting Postmarketing Requirements and Commitments.” The report shows that an average of 264 postmarketing requirements (PMRs) were established each year since FY 2011\. Most PMRs that were established in earlier years were either fulfilled or released. Overall, of the PMRs that were pending as of September 30, 2017, 79% (432/548) were created within the past three years. On average, 10% (179/1851) of the PMRs established since FY2011 were delayed as of 9/30/2017\. For postmarketing commitments (PMCs), an average of 58 were established each year since FY 2011\. Most PMCs that were established in the earlier years were either fulfilled or released. Overall, of the PMCs that were pending as of 9/30/2017, 90% (86/96) were created within the past three years. On average, 5% (20/403) of the PMCs established since FY 2011 were delayed as of 9/30/2017\. The report can be downloaded [here](https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Post-marketingPhaseIVCommitments/UCM623499.pdf?ref=fdaweb.com). To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2018-25128.pdf?ref=fdaweb.com).